News from Aptiv, Truveris and CMI – People on the move
Outsourcing-Pharma presents its weekly round-up of the latest new appointments in the pharmaceutical industry, including news from Aptiv, Truveris and CMI.
Outsourcing-Pharma presents its weekly round-up of the latest new appointments in the pharmaceutical industry, including news from Aptiv, Truveris and CMI.
EMD Millipore premiered a new single-use bioreactor at Interphex 2012, claiming the new design addresses industry demand for ease of use and flexibility.
IPEC India will be formally established by the end of June according to incoming chairman Ajit Singh of Mumbai-based ACG Worldwide.
The US FDA has updated its preclinical testing requirements for biotech drugs citing advances since the publication of ICH S6 and the need to harmonize with international standards.
Evotec and 4-Antibody have teamed up to offer a new antibody testing service.
The CEO of PDI said the contract sales market has “shrunk” over the past few quarters as the flow of business awards has dried up.
Developments in single-use technology signals the end for clean-in-place biomanufacturing methods, according to ThermoFisher’s Bill Whitford.
Mitsubishi Tanabe Pharma (MTP) is to withdraw from the fine chemicals sector and transfer all pharmaceutical ingredient production to a subsidiary.